Matinas Biopharma Holdings Total Assets 2012-2019 | MTNB

Matinas Biopharma Holdings total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Matinas Biopharma Holdings Annual Total Assets
(Millions of US $)
2018 $20
2017 $14
2016 $10
2015 $8
2014 $3
2013 $11
2012 $0
2011 $0
Matinas Biopharma Holdings Quarterly Total Assets
(Millions of US $)
Q2 2019 $48
Q1 2019 $51
Q4 2018 $20
Q3 2018 $14
Q2 2018 $16
Q1 2018 $11
Q4 2017 $14
Q3 2017 $17
Q2 2017 $18
Q1 2017 $22
Q4 2016 $10
Q3 2016 $11
Q2 2016 $6
Q1 2016 $7
Q4 2015 $8
Q3 2015 $10
Q2 2015 $12
Q1 2015 $10
Q4 2014 $3
Q3 2014 $6
Q2 2014 $7
Q1 2014 $9
Q4 2013 $11
Q3 2013 $13
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q4 2011 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.102B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.991B 36.95
Astellas Pharma (ALPMY) Japan $28.057B 13.37
Takeda Pharmaceutical (TAK) Japan $27.169B 8.48
Merck (MKGAF) Germany $14.591B 19.91
Eisai (ESALY) Japan $14.446B 24.84
Grifols, S.A (GRFS) Spain $14.102B 17.99
UCB SA (UCBJF) Belgium $13.914B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.234B 0.00
Ionis Pharmaceuticals (IONS) United States $8.811B 19.00
Sage Therapeutics (SAGE) United States $8.540B 0.00
IPSEN SA ADR (IPSEY) France $8.336B 0.00
Catalent (CTLT) United States $7.535B 29.83
Jazz Pharmaceuticals (JAZZ) Ireland $7.316B 9.63
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.058B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.146B 18.50
United Therapeutics (UTHR) United States $3.771B 0.00
Nektar Therapeutics (NKTR) United States $3.532B 0.00
FibroGen (FGEN) United States $3.468B 86.74
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.125B 11.20
Tilray (TLRY) Canada $2.832B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.736B 62.74
PTC Therapeutics (PTCT) United States $2.302B 0.00
Xencor (XNCR) United States $2.090B 45.57
Portola Pharmaceuticals (PTLA) United States $2.075B 0.00
Zogenix (ZGNX) United States $1.833B 0.00
Corcept Therapeutics (CORT) United States $1.602B 22.02
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.549B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.547B 56.30
USANA Health Sciences (USNA) United States $1.532B 15.36
Ironwood Pharmaceuticals (IRWD) United States $1.482B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.412B 23.29
Radius Health (RDUS) United States $1.313B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.279B 0.00
Aerie Pharmaceuticals (AERI) United States $1.072B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.010B 0.00
ArQule (ARQL) United States $1.009B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.999B 4.45
TherapeuticsMD (TXMD) United States $0.895B 0.00
Endo (ENDP) Ireland $0.788B 1.39
Catalyst Pharmaceuticals (CPRX) United States $0.682B 0.00
Concordia (CXRXF) Canada $0.673B 0.00
Karyopharm Therapeutics (KPTI) United States $0.664B 0.00
Organogenesis Holdings (ORGO) United States $0.635B 0.00
Flexion Therapeutics (FLXN) United States $0.570B 0.00
Lannett Co Inc (LCI) United States $0.558B 5.87
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.556B 0.00
Akebia Therapeutics (AKBA) United States $0.536B 0.00
Translate Bio (TBIO) United States $0.514B 0.00
ImmunoGen (IMGN) United States $0.496B 0.00
Aptorum Group (APM) China $0.485B 0.00
Indivior (INVVY) United States $0.466B 1.68
Innate Pharma SA (IPHYF) France $0.455B 0.00
Siga Technologies (SIGA) United States $0.450B 1.05
Dermira (DERM) United States $0.449B 0.00
ChemoCentryx (CCXI) United States $0.435B 0.00
Dova Pharmaceuticals (DOVA) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 19.25
DURECT (DRRX) United States $0.411B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.394B 0.00
Collegium Pharmaceutical (COLL) United States $0.389B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.340B 0.00
Harpoon Therapeutics (HARP) United States $0.340B 0.00
OptiNose (OPTN) United States $0.328B 0.00
Ardelyx (ARDX) United States $0.325B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.316B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.276B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.276B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.271B 0.00
Recro Pharma (REPH) United States $0.266B 0.00
Concert Pharmaceuticals (CNCE) United States $0.257B 0.00
Molecular Templates (MTEM) United States $0.254B 0.00
CV Sciences (CVSI) United States $0.252B 0.00
KalVista Pharmaceuticals (KALV) United States $0.243B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.221B 0.00
Calithera Biosciences (CALA) United States $0.209B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.199B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
GlycoMimetics (GLYC) United States $0.190B 0.00
CannTrust Holdings (CTST) Canada $0.185B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 30.65
Redhill Biopharma (RDHL) Israel $0.167B 0.00
IMV INC (IMV) Canada $0.167B 0.00
Generex Biotechnology (GNBT) United States $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
ElectroCore (ECOR) United States $0.148B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.136B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.121B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.113B 0.00
Jounce Therapeutics (JNCE) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Majesco Entertainment (PTE) United States $0.107B 0.00
Mast Therapeutics (SVRA) United States $0.105B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
MediWound (MDWD) Israel $0.090B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.089B 0.00
Iterum Therapeutics (ITRM) Ireland $0.088B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.65
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Aquestive Therapeutics (AQST) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.077B 7.66
Novan (NOVN) United States $0.072B 0.00
Lipocine (LPCN) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Otonomy (OTIC) United States $0.067B 0.00
Jaguar Animal Health (JAGX) United States $0.067B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.059B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.053B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.63
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Onconova Therapeutics (ONTX) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
VAXART, INC (VXRT) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00